FindTrial
Sign In

To study the role of Eladi Kwatha with Sharkara and Madhu in atyadhik yonigata raktastrava with special reference to Abnormal uterine bleeding

An open label single arm clinical study of Eladi Kwatha with Sharkara and Madhu in Yonipravaha with special reference to Abnormal Uterine Bleeding

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033360
Enrollment
30
Registered
2021-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E349- Endocrine disorder, unspecified

Interventions

Intervention1: Eladi Kwatha With Sharkara and Madhu: will be given 20ml four times a day for 5 days Control Intervention1: nil: nil

Sponsors

Kalyani Mitalkumar Mahajan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients between the age group 15-45 yrs Both married and unmarried women Patients having Abnormal Uterine Bleeding with excessive and prolonged menstrual bleeding

Exclusion criteria

Exclusion criteria: Patients taking anti coagulation therapy and having any coagulation defect. Patients with severe malnutrition and severe anemia (Hb Threatened, spontaneous or incomplete abortion/ectopic pregnancy, trophoblastic diseases, placental abnormalities and Antepartum Hemorrhage. Patients with systemic diseases like uncontrolled D.M. and T.B. History of documented vascular disease like coronary artery disease, cerebrovascular disease or stroke, transient ischemic attack, peripheral vascular disease and DVT. Condition like endometrial cancer of cervix, etc. Bleeding from Reproductive Track due to traumatic causes, motor vehicle accident and IC

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Eladi Kwatha with Sharkara and Madhu in Yonipravaha. Timepoint: day 1 to day 5 of Abnormal uterine bleeding—

Secondary

MeasureTime frame
Adverse effect of drug Eladi Kwatha with Sharkara and Madhu will be observed during clinical study, if any.Timepoint: 18 months of study period—

Countries

India

Contacts

Public ContactDr Trupti Kalyan Gawade

Sumatibhai Shah Ayurved Mahavidyalaya

truptigawade13@gmail.com9881840224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026